Staphylococcus aureus bacteraemia in Gauteng academic hospitals, South Africa

被引:32
|
作者
Fortuin-de Smidt, Melony C. [1 ]
Singh-Moodley, Ashika [1 ,2 ]
Badat, Rubeina [1 ]
Quan, Vanessa [1 ]
Kularatne, Ranmini [2 ,3 ]
Nana, Trusha [2 ,3 ]
Lekalakala, Ruth [4 ,5 ]
Govender, Nelesh P. [1 ,2 ]
Perovic, Olga [1 ,2 ]
机构
[1] Ctr Opportunist Trop & Hosp Infect, NICD, ZA-2132 Johannesburg, Gauteng, South Africa
[2] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[3] Natl Hlth Lab Serv, Johannesburg, South Africa
[4] Univ Pretoria, Fac Hlth Sci, Dept Med Microbiol, Gauteng, South Africa
[5] Natl Hlth Lab Serv, Tshwane Acad Div, Gauteng, South Africa
关键词
Staphylococcus aureus; Bacteraemia; Methicillin-resistant; HIV infection; Mortality; ACQUIRED METHICILLIN-RESISTANT; PANTON-VALENTINE LEUKOCIDIN; RISK-FACTORS; ANTIMICROBIAL SUSCEPTIBILITY; SCCMEC TYPE; MORTALITY; INFECTION; COLONIZATION; EPIDEMIOLOGY; OUTCOMES;
D O I
10.1016/j.ijid.2014.10.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) infections are responsible for longer hospital stays, increased hospital costs, and poorer outcomes compared to methicillin-sensitive S. aureus (MSSA) infections. We aimed to describe the epidemiology of S. aureus bacteraemia (SAB) and to determine factors associated with MRSA infection in South Africa. Methods: Cases of SAB were reported from September 2012 to September 2013 from three sentinel sites. A case was defined as the isolation of S. aureus from a blood culture during a 21-day period. Detailed clinical information was collected. Multivariable logistic regression was done to determine factors associated with MRSA infection and mortality. Results: There were 442 cases of SAB reported; antimicrobial susceptibility testing was performed on 240 isolates (54%). Thirty-six percent (861240) of cases had an MRSA infection. A longer hospital stay before positive specimen collection (odds ratio (OR) 1.08, 95% confidence interval (CI) 1.02-1.13, p = 0.004), hospitalization in the last year (OR 15.7,95% CI 2.5-99.5,p = 0.003), HIV infection (OR 4.9, 95% CI 1.05-22.90, p = 0.044), and antibiotic use in the previous 2 months (OR 0.1, 95% CI 0.01-0.68, p = 0.022) were independent predictors of MRSA. Older age, and in particular age 25-44 years (OR 22.2, 95% CI 2.7-185.5, p = 0.004, compared to those aged < 5 years), was the only independent predictor of mortality amongst cases with SAB. MRSA isolates were non-susceptible to more antimicrobial agents compared to MSSA isolates. Conclusions: HIV infection was an independent risk factor for MRSA infection. The selection of appropriate empirical antimicrobial treatment is essential in patients with MRSA infections because of non-susceptibility to many other antimicrobial classes. (C) 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 50 条
  • [41] Staphylococcus aureus bacteraemia cases at Helen Joseph Hospital
    John, Mithra
    Richards, Lauren
    Nel, Jeremy S.
    [J]. SOUTHERN AFRICAN JOURNAL OF INFECTIOUS DISEASES, 2024, 39 (01)
  • [42] The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia
    Siegman-Igra, Y
    Reich, P
    Orni-Wasserlauf, R
    Schwartz, D
    Giladi, M
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2005, 37 (08) : 572 - 578
  • [43] Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia
    Blyth, CC
    Darragh, H
    Whelan, A
    O'Shea, JP
    Beaman, MH
    McCarthy, JS
    [J]. INTERNAL MEDICINE JOURNAL, 2002, 32 (5-6) : 224 - 232
  • [44] Metastatic Spreading of Community Acquired Staphylococcus aureus Bacteraemia
    Fabio, Giovanna
    Carrabba, Maria
    Mellace, Luca
    Hu, Cinzia
    Spagnoli, Diego
    Cappellini, Andmaria Domenica
    [J]. CASE REPORTS IN INFECTIOUS DISEASES, 2011, 2011
  • [45] Staphylococcus aureus bacteraemia: does duration matter? Comment
    Tong, Steven Y. C.
    Lee, Todd C.
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (12): : 1353 - 1354
  • [46] Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review
    Asgeirsson, Hilmir
    Thalme, Anders
    Weiland, Ola
    [J]. INFECTIOUS DISEASES, 2018, 50 (03) : 175 - 192
  • [47] How to investigate and manage a patient with a Staphylococcus aureus bacteraemia
    Florman, Katia
    Jones, Howell T.
    Moores, Rachel
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2021, 82 (09)
  • [48] Optimal drug therapy for Staphylococcus aureus bacteraemia in adults
    Legg, Amy
    Davis, Joshua S.
    Roberts, Jason A.
    [J]. CURRENT OPINION IN CRITICAL CARE, 2023, 29 (05) : 446 - 456
  • [49] Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infections
    Butt, Jawad H.
    Fosbol, Emil L.
    Gerds, Thomas A.
    Iversen, Kasper
    Bundgaard, Henning
    Bruun, Niels Eske
    Larsen, Anders R.
    Petersen, Andreas
    Andersen, Paal S.
    Skov, Robert L.
    Ostergaard, Lauge
    Havers-Borgersen, Eva
    Gislason, Gunnar H.
    Torp-Pedersen, Christian
    Kober, Lars
    Olesen, Jonas B.
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (01) : 13 - 19
  • [50] Development of quality indicators for the management of Staphylococcus aureus bacteraemia
    ten Oever, Jaap
    Jansen, Joell L.
    van der Vaart, Thomas W.
    Schouten, Jeroen A.
    Hulscher, Marlies E. J. L.
    Verbon, Annelies
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (11) : 3344 - 3351